Nelson LM, Copley-Merriman K, Norquist J, Powers J. PRO evidence dossier: evidence to support labeling and promotional claims for FDA-regulated medicine products. Poster presented at the International Society for Quality of Life Research Workshop #3; October 2009.
Nelson LM, McLeod LD, Lee J, Hill C, Sweeney CT, Sun P. Effects of insulin therapy on the Diabetes Symptom Checklist-Revised (DSC-R): data from a large insulin clinical trial. Presented at the 2009 16th Annual Conference of the International Society for Quality of Life Research; October 2009. New Orleans, LA.
Lee J, McLeod LD, Nelson LM, Hill C, Sweeney CT, Sun P. Initiation of insulin therapy improves self-reported diabetes symptoms in patients (Pts) with type 2 diabetes (T2D) on oral agents. Poster presented at the 69th Scientific Sessions of the American Diabetes Association; June 2009.
Lee LJ, Nelson LM, McLeod LD, Hill CD, Sweeney CT. Effects of insulin therapy on the Diabetes Symptom Checklist-Revised (DSC-R): data from a large insulin clinical trial. Poster presented at the 2009 ISPOR 14th Annual International Meeting; May 21, 2009. [abstract] Value Health. 12(3):A105.
Macdougall JE, Erder MH, Nelson LM, Price MA, Williams VS, Johnston JM. Correlational structure of IBS-C PRO symptom measures determined by exploratory factor analysis an relationship to global PRO assessments: results from a phase 2 trial of linaclotide in IBS-C. Poster presented at the 2009 NGM Scientific Meeting; 2009.